What type of study is this?

This is a Case-Control Study study (also classified as: Quantitative Study).

October 27, 2025Medical SciencesOpen Access

Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic Imaging

View Full Paper

Ask AI

Bookmark

All tumor cases classified as true positive, demonstrating precise predictive capabilities with 100% sensitivity.
Absolute differences between predicted and observed tumor volumes ranged from 0.07 to 0.33 cm3.
Tumor growth modeled using partial differential equations within a reaction-diffusion mass transfer framework.
Findings highlight the feasibility of integrating imaging with modeling for patient-specific treatment predictions.

No takes yet. Share an insight, caveat, or question.

Proof-of-concept case study demonstrates neoadjuvant therapy predictions in breast cancer, suggesting potential advancements in personalized metrics.

Marino et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Proof-of-concept case study demonstrates neoadjuvant therapy predictions in breast cancer, suggesting potential advancements in personalized metrics.